• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白光增强铱(III)配合物对肺癌 A549 细胞的抗癌效果。

White light increases anticancer effectiveness of iridium(III) complexes toward lung cancer A549 cells.

机构信息

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China.

Department of Pharmacy, Guangdong Second Provincial General Hospital, 510317, PR China.

出版信息

J Inorg Biochem. 2024 Oct;259:112652. doi: 10.1016/j.jinorgbio.2024.112652. Epub 2024 Jun 26.

DOI:10.1016/j.jinorgbio.2024.112652
PMID:38945112
Abstract

Anticancer activity has been extensively studies. In this article, three ligands 2-(6-bromobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (BDIP), 2-(7-methoxybenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (MDIP), 2-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (NDIP) and their iridium(III) complexes: Ir(ppy)(BDIP) (ppy = deprotonated 2-phenylpyridine, 3a), Ir(ppy)(MDIP) (3b) and Ir(ppy)(NDIP) (3c) were synthesized. The cytotoxicity of 3a, 3b, 3c against Huh7, A549, BEL-7402, HepG2, HeLa, and non-cancer NIH3T3 was tested using 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. The results obtained from the MTT test stated clearly that these complexes demonstrated moderate or non-cytotoxicity toward Huh7, BEL-7402, HepG2 and HeLa except A549 cells. To improve the anticancer efficacy, we used white light to irradiate the mixture of cells and complexes for 30 min, the anticancer activity of the complexes was greatly enhanced. Particularly, 3a and 3b exhibited heightened capability to inhibit A549 cells proliferation with IC (half maximal inhibitory concentration) values of 0.7 ± 0.3 μM and 1.8 ± 0.1 μM, respectively. Cellular uptake has shown that 3a and 3b can be accumulated in the cytoplasm. Wound healing and colony forming showed that 3a and 3b significantly hinder the cell migration and growth in the S phase. The complexes open mitochondrial permeability transition pore (MPTP) channel and cause the decrease of membrane potential, release of cytochrome C, activation of caspase 3, and finally lead to apoptosis. In addition, 3a and 3b cause autophagy, increase the lipid peroxidation and lead to ferroptosis. Also, 3a and 3b increase the expression of calreticulin (CRT), high mobility group box 1 (HMGB1), heat shock protein 70 (HSP70), thereby inducing immunogenic cell death.

摘要

抗癌活性已得到广泛研究。在本文中,我们合成了三种配体 2-(6-溴苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(BDIP)、2-(7-甲氧基苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(MDIP)、2-(6-硝基苯并[1,3]二氧杂环戊烯-5-基)-1H-咪唑并[4,5-f][1,10]菲咯啉(NDIP)及其铱(III)配合物:[Ir(ppy)(BDIP)](PF)(ppy=去质子化 2-苯基吡啶,3a)、[Ir(ppy)(MDIP)](PF)(3b)和[Ir(ppy)(NDIP)](PF)(3c)。采用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐(MTT)法检测了 3a、3b、3c 对 Huh7、A549、BEL-7402、HepG2、HeLa 和非癌细胞 NIH3T3 的细胞毒性。MTT 试验结果清楚地表明,这些配合物对 Huh7、BEL-7402、HepG2 和 HeLa (除 A549 细胞外)表现出中等或非细胞毒性。为了提高抗癌效果,我们使用白光照射细胞和配合物的混合物 30 分钟,配合物的抗癌活性大大增强。特别是 3a 和 3b 表现出抑制 A549 细胞增殖的能力,IC(半最大抑制浓度)值分别为 0.7±0.3μM 和 1.8±0.1μM。细胞摄取表明 3a 和 3b 可以在细胞质中积累。划痕愈合和集落形成实验表明,3a 和 3b 可显著抑制细胞迁移和 S 期生长。配合物打开线粒体通透性转换孔(MPTP)通道,导致膜电位降低、细胞色素 C 释放、半胱天冬酶 3 激活,最终导致细胞凋亡。此外,3a 和 3b 引起自噬,增加脂质过氧化,导致铁死亡。同时,3a 和 3b 增加钙网蛋白(CRT)、高迁移率族蛋白 1(HMGB1)和热休克蛋白 70(HSP70)的表达,从而诱导免疫原性细胞死亡。

相似文献

1
White light increases anticancer effectiveness of iridium(III) complexes toward lung cancer A549 cells.白光增强铱(III)配合物对肺癌 A549 细胞的抗癌效果。
J Inorg Biochem. 2024 Oct;259:112652. doi: 10.1016/j.jinorgbio.2024.112652. Epub 2024 Jun 26.
2
Mitochondrial-targeted iridium(III) complexes suppress tumor growth through inducting immunogenic cell death to activate immune response.线粒体靶向铱(III)配合物通过诱导免疫原性细胞死亡来激活免疫反应,从而抑制肿瘤生长。
Eur J Med Chem. 2025 Nov 5;297:117926. doi: 10.1016/j.ejmech.2025.117926. Epub 2025 Jul 1.
3
Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.通过内质网应激-线粒体功能障碍途径诱导 SGC-7901 细胞凋亡的铱(III)配合物。
J Biol Inorg Chem. 2022 Aug;27(4-5):455-469. doi: 10.1007/s00775-022-01943-6. Epub 2022 Jul 11.
4
Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.脂质体包裹的铱(III)多吡啶配合物增强了体外和体内的抗癌活性。
J Inorg Biochem. 2020 Apr;205:111014. doi: 10.1016/j.jinorgbio.2020.111014. Epub 2020 Jan 31.
5
Synthesis, characterization and induction of ferroptosis of iridium(III) complexes against B16 melanoma cells.铱(III)配合物对B16黑色素瘤细胞的合成、表征及铁死亡诱导作用
Dalton Trans. 2025 Jun 17;54(24):9503-9516. doi: 10.1039/d5dt00899a.
6
Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo.铱(III)-BBIP 配合物通过 PI3K/AKT/mTOR 通路诱导细胞凋亡,并抑制体内 A549 肺肿瘤生长。
J Inorg Biochem. 2021 Oct;223:111550. doi: 10.1016/j.jinorgbio.2021.111550. Epub 2021 Jul 21.
7
Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.光激活铱(III)配合物对肺癌 A549 细胞的抗癌活性及作用机制研究。
Dalton Trans. 2024 Sep 18;53(36):15176-15189. doi: 10.1039/d4dt01677g.
8
Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.光激活铱(III)配合物促进活性氧产生和 DNA 损伤,增强 A549 细胞中的抗癌活性。
J Inorg Biochem. 2022 Nov;236:111977. doi: 10.1016/j.jinorgbio.2022.111977. Epub 2022 Aug 23.
9
Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis.铱(III)配合物包封在脂质体中可引发线粒体介导的细胞凋亡和 GSDME 介导的细胞焦亡。
J Inorg Biochem. 2022 Mar;228:111706. doi: 10.1016/j.jinorgbio.2021.111706. Epub 2022 Jan 5.
10
Designing novel tridentate iridium(III) complexes comprising functionalized benzothiazole ligands to improve anticancer activity by targeting mitochondria.设计包含功能化苯并噻唑配体的新型三齿铱(III)配合物,通过靶向线粒体提高抗癌活性。
Bioorg Chem. 2025 Jul 1;161:108507. doi: 10.1016/j.bioorg.2025.108507. Epub 2025 Apr 22.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Metal-based molecules in the treatment of cancer: From bench to bedside.用于癌症治疗的金属基分子:从实验室到临床应用
Oncol Res. 2025 Mar 19;33(4):759-779. doi: 10.32604/or.2024.057019. eCollection 2025.